Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology.
about
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsAdvanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug DeliveryIntraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects metabolic reprogramming and effectively inhibits cancer stem cells in Taxol(®)-resistant ovarian cancerDirect Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse OriginStimulation of vascularization of a subcutaneous scaffold applicable for pancreatic islet-transplantation enhances immediate post-transplant islet graft function but not long-term normoglycemia.Efficacy and Safety of Vincristine Sulfate Liposome Injection in the Treatment of Adult Acute Lymphocytic Leukemia.Comparison of the pharmacokinetic profiles of two different amphotericin B formulations in healthy dogs.A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems.Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies.The significance of drug-to-lipid ratio to the development of optimized liposomal formulation.
P2860
Q28066801-A318199C-7339-430A-9F7A-9E3CF793F30DQ28076132-727D835E-F2A5-49A7-B5F4-2E7125BCC37AQ35826455-0FC3B7BB-2DC2-4D11-BE4C-C0D634D570A0Q37231321-E33C686C-F1FB-41A5-8E09-0CC534B7461EQ38805571-BCE73043-6F18-4EAD-8FEC-1425BE30CE31Q38872343-67F4F2C6-94F7-40F9-8FF6-63E0C4D5CF1BQ40090449-5A10D297-6A8F-4387-9982-8913B6B2B6E5Q41518143-22C4BE37-BD7B-4EB8-B744-1DABEE71D315Q45932069-6D487835-E2E0-455F-8C94-6FC607F7C288Q53687867-8E3ACCD0-ADD0-47E4-BE66-EDA1177D6155
P2860
Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Application of pharmacokinetic ...... mal formulations for oncology.
@en
Application of pharmacokinetic ...... mal formulations for oncology.
@nl
type
label
Application of pharmacokinetic ...... mal formulations for oncology.
@en
Application of pharmacokinetic ...... mal formulations for oncology.
@nl
prefLabel
Application of pharmacokinetic ...... mal formulations for oncology.
@en
Application of pharmacokinetic ...... mal formulations for oncology.
@nl
P2093
P2860
P1433
P1476
Application of pharmacokinetic ...... mal formulations for oncology.
@en
P2093
Donald E Mager
Robert M Straubinger
Sihem Ait-Oudhia
P2860
P304
P356
10.3390/PHARMACEUTICS6010137
P577
2014-03-18T00:00:00Z